Covered recipient · General Payments record
RICHARD CASS
Allopathic & Osteopathic Physicians Colon & Rectal Surgery
General Payments · PY2023–2024
$1,160.41
- Reported across 14 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $352.61 | 11 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| DAVOL INC. | $152.10 | 1 |
| Lilly USA, LLC | $60.23 | 3 |
| Exact Sciences Corporation | $45.13 | 2 |
| Novo Nordisk AS | $36.45 | 2 |
| Renalytix AI, Inc. | $34.89 | 2 |
| Merck Sharp & Dohme Corporation | $23.81 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (11)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Davol Inc. | $152.10 | 12/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1127664827 | CMS |
| Exact Sciences Corporation | $23.69 | 07/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114609823 | CMS |
| Exact Sciences Corporation | $21.44 | 10/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114609818 | CMS |
| Lilly USA, LLC | $14.59 | 03/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135367554 | CMS |
| Lilly USA, LLC | $23.73 | 03/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135390167 | CMS |
| Lilly USA, LLC | $21.91 | 06/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135377916 | CMS |
| Merck Sharp & Dohme LLC | $23.81 | 11/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141752038 | CMS |
| Novo Nordisk Inc | $19.37 | 07/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097411583 | CMS |
| Novo Nordisk Inc | $17.08 | 12/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097253431 | CMS |
| Renalytix AI, Inc. | $14.25 | 07/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116758630 | CMS |
| Renalytix AI, Inc. | $20.64 | 09/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116758632 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2023, 2024
- Source files
- Dataset page · Bulk file · PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.